{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:17:49Z","timestamp":1787062669938,"version":"build-2736575974"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"JSPS KAKENHI","award":["16H00483"],"award-info":[{"award-number":["16H00483"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.jiac.2018.10.013","type":"journal-article","created":{"date-parts":[[2018,11,10]],"date-time":"2018-11-10T09:18:24Z","timestamp":1541841504000},"page":"124-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Correlation between vancomycin penetration into cerebrospinal fluid and protein concentration in cerebrospinal fluid\/serum albumin ratio"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8510-9392","authenticated-orcid":false,"given":"Masayuki","family":"Ishikawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Iwadate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itsuko","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2018.10.013_bib1","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1586\/14787210.2015.1077700","article-title":"Bacterial meningitis: an update of new treatment options","volume":"13","author":"Nau","year":"2015","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jiac.2018.10.013_bib2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2146\/ajhp080434","article-title":"Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American society of health-system pharmacists, the infecious diseases society of America, and the society of infectious diseases pharmacists","volume":"66","author":"Rybak","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jiac.2018.10.013_bib3","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1128\/AAC.43.4.876","article-title":"Pharmacodynamics of vancomycin for the treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis","volume":"43","author":"Ahmed","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2018.10.013_bib4","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1086\/510390","article-title":"Levels of vancomycin in cerebrospinal fluid of adult patients receiving adjunctive corticosteroids to treat pneumococcal meningitis: a prospective multicenter observational study","volume":"44","author":"Ricard","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2018.10.013_bib5","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1128\/CMR.00007-10","article-title":"Penetration of drugs through the blood-cerebrospinal fluid\/blood-brain barrier for treatment of central nervous system infections","volume":"23","author":"Nau","year":"2010","journal-title":"Clin Microbiol Rev"},{"issue":"42 Suppl 1","key":"10.1016\/j.jiac.2018.10.013_bib6","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1086\/491712","article-title":"The pharmacokinetic and pharmacodynamic properties of vancomycin","volume":"1","author":"Rybak","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2018.10.013_bib7","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/s40262-017-0548-y","article-title":"Penetration of vancomycin into the cerebrospinal fluid: a systematic review","volume":"56","author":"Beach","year":"2017","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jiac.2018.10.013_bib8","doi-asserted-by":"crossref","first-page":"812.e1","DOI":"10.1016\/j.wneu.2016.12.076","article-title":"Is first-line vancomycin still the best option to treat staphylococcus health care-associated meningitis?","volume":"99","author":"Mounier","year":"2017","journal-title":"World Neurosurg"},{"key":"10.1016\/j.jiac.2018.10.013_bib9","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/978-3-319-01225-4_9","article-title":"CSF albumin: albumin CSF\/serum ratio (marker for blood-CSF barrier function)","author":"Tumani","year":"2015","journal-title":"Cerebrospinal Fluid Clin Neurol"},{"key":"10.1016\/j.jiac.2018.10.013_bib10","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/ncn3.158","article-title":"Importance of the quotient of albumin, quotient of immunoglobulin G and Reibergram in inflammatory neurological disorders with disease-specific patterns of blood-brain barrier permeability","volume":"3","author":"Akaishi","year":"2015","journal-title":"Neurol Clin Neurosci"},{"key":"10.1016\/j.jiac.2018.10.013_bib11","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1002\/jps.24604","article-title":"Population pharmacokinetics of vancomycin in postoperative neurosurgical patients","volume":"104","author":"Li","year":"2015","journal-title":"J\u00a0Phram Sci"},{"key":"10.1016\/j.jiac.2018.10.013_bib12","first-page":"144","article-title":"Criteria for clinical evaluation of antibiotics in the pediatric field","volume":"51","author":"Fujii","year":"2003","journal-title":"Jpn J Antibiot"},{"key":"10.1016\/j.jiac.2018.10.013_bib13","first-page":"17","article-title":"Estimation of regression parameters from data with detection and quantitation limits","volume":"43","author":"Abe","year":"2006","journal-title":"J\u00a0Facul Sci Technol Seikei Univ"},{"key":"10.1016\/j.jiac.2018.10.013_bib14","first-page":"404","article-title":"Influence of cerebrospinal fluid drainage on the pharmacokinetics of vancomycin in neurosurgical patients","volume":"70","author":"Ichie","year":"2015","journal-title":"Pharmazie"},{"key":"10.1016\/j.jiac.2018.10.013_bib15","first-page":"424","article-title":"Determination of vancomycin trough level in serum and cerebrospinal fluid of patients with acute community-acquired meningitis: a prospective study","volume":"69","author":"Shoukouhi","year":"2014","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.jiac.2018.10.013_bib16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s15010-005-4083-7","article-title":"Coagulase-negative staphylococcal meningitis in adults: clinical characteristics and therapeutic outcomes","volume":"33","author":"Huang","year":"2005","journal-title":"Infection"},{"key":"10.1016\/j.jiac.2018.10.013_bib17","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1007\/s00701-015-2574-6","article-title":"Clinical, biological, and microbiological pattern associated with ventriculostomy-related infection: a retrospective longitudinal study","volume":"157","author":"Mounier","year":"2015","journal-title":"Acta Neurochir (Wien)"},{"key":"10.1016\/j.jiac.2018.10.013_bib18","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1136\/jnnp.2008.165357","article-title":"Prospective surveillance of drain associated meningitis\/ventriculitis in a neurosurgery and neurological intensive care unit","volume":"80","author":"Scheithauer","year":"2009","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jiac.2018.10.013_bib19","first-page":"1001","article-title":"Conversion of external ventricular drains to ventriculoperitoneal shunts after aneurysmal subarachnoid hemorrhage: effects of site and protein\/red blood cell counts on shunt infection and malfunction","volume":"109","author":"Rammos","year":"2008","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.jiac.2018.10.013_bib20","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1128\/AAC.00051-06","article-title":"Serum and cerebrospinal fluid concentrations of linezolid in neurosurgical patients","volume":"50","author":"Myrianthefs","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2018.10.013_bib21","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.surneu.2007.01.073","article-title":"Postoperatively administered vancomycin reaches therapeutic concentration in the cerebral spinal fluid of neurosurgical patients","volume":"69","author":"Wang","year":"2008","journal-title":"Surg Neurol"},{"key":"10.1016\/j.jiac.2018.10.013_bib22","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1097\/INF.0000000000000385","article-title":"Vancomycin cerebrospinal fluid pharmacokinetics in children with cerebral ventricular shunt infections","volume":"33","author":"Autmizguine","year":"2014","journal-title":"Pediatr Infect Dis J"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X18304264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X18304264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:57:23Z","timestamp":1761159443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X18304264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S1341321X18304264"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2018.10.013","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation between vancomycin penetration into cerebrospinal fluid and protein concentration in cerebrospinal fluid\/serum albumin ratio","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2018.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}